PLX

2.9005.23%
GM

Gilad Mamlok

Independent Non-Executive Director

Mr. Gilad Mamlok is Independent Non-Executive Director of Ellomay Capital Ltd. from March 4, 2026. Mr. Mamlok is Chief Financial Officer of TytoCare Ltd. Mr. Mamlok is Senior Vice President and Chief Financial Officer at Protalix BioTherapeutics, Inc. since August 24, 2025. He served as the Chief Financial Officer of TytoCare Ltd., a privately-held company in the remote healthcare space. He was Chief Financial Officer at Sol-Gel Technologies Ltd. since February 2017 until July 12, 2024. Mr. Mamlok served as the Chief Financial Officer of MediGus Ltd. from August 1, 2015 to January 31, 2017. Mr. Mamlok has over two decades of Financial Management and Business Development Experience. He served as Vice President of Finance at Covidien plc, following its acquisition of Given Imaging, where he served as Senior Vice President of Global Finance and Accounting since September 2005 until March 2015. He served as Chief Financial Officer of Metacure Ltd. from 2004 to 2005 and of Simbionix Ltd. from 2002 to 2004 and a Director of Finance at Nice Ltd. from 1997 to 2001. He was previously at the helm of corporate financial planning, including leading mergers and acquisitions, investor relations and corporate governance, for several public and private medical device and technology companies located in Israel and the United States. Mr. Mamlok holds a Master's degree in Business/Managerial Economics from Tel-Aviv University and a B.A. in Economics (magna cum laude) from Tel-Aviv University.

Positions